Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.26 USD | -6.55% |
|
-5.49% | -34.90% |
06-04 | Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses | CI |
05-09 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.90% | 1.05B | |
+23.13% | 52.73B | |
+37.49% | 39B | |
-8.73% | 38.52B | |
+28.09% | 30.38B | |
-12.26% | 26.39B | |
+10.57% | 26.08B | |
+45.05% | 14.15B | |
+32.23% | 12.6B | |
-6.56% | 11.51B |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- Pharvaris Files Mixed Shelf